LAVA Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Jan '20 Jan 1, 2020
Cash & Equivalents	35.09	44.23	100.33	90.87	15.82	7.34
Short-Term Investments	51.71	51.34	32.54	42.33	-	-
Cash & Short-Term Investments	86.8	95.57	132.87	133.2	15.82	7.34
Cash Growth	-22.78%	-28.07%	-0.25%	742.10%	115.56%	-
Accounts Receivable	0.58	1.46	3.25	0.36	1.14	0.07
Other Receivables	0.57	0.24	-	0.37	0.34	0.15
Receivables	1.15	1.7	3.25	0.73	1.48	0.22
Prepaid Expenses	2.22	1.63	4.41	2.57	0.12	0.06
Other Current Assets	-	-	-	-	0.81	-
Total Current Assets	90.17	98.9	140.53	136.51	18.22	7.62
Property, Plant & Equipment	1.97	2.49	2.08	1.95	1.5	1.15
Other Long-Term Assets	0.14	0.32	0.81	0.8	0.77	0.03
Total Assets	92.28	101.71	143.43	139.25	20.49	8.8
Accounts Payable	4.16	4.45	3.97	2.55	0.93	0.42
Accrued Expenses	4.08	4.29	7.83	1.57	1.27	0.75
Current Portion of Long-Term Debt	5.38	5.28	4.64	-	-	-
Current Portion of Leases	0.49	0.44	0.38	0.26	0.21	0.24
Current Unearned Revenue	-	-	-	1.53	4.52	-
Other Current Liabilities	-	0.48	5.14	5.34	0.41	0.01
Total Current Liabilities	14.11	14.94	21.95	11.25	7.34	1.42
Long-Term Debt	-	-	-	4.28	3.6	1.27
Long-Term Leases	0.3	0.59	0.43	0.32	0.27	0.26
Long-Term Unearned Revenue	35	35	35	-	1.66	-
Other Long-Term Liabilities	-	-	-	5.03	-	-
Total Liabilities	49.41	50.53	57.39	20.88	12.87	2.95
Common Stock	3.72	3.72	3.72	3.65	-	-
Additional Paid-In Capital	194.45	194.42	194.42	192.27	41.09	19.56
Retained Earnings	-156.72	-148.07	-108.07	-76.16	-33.39	-13.7
Comprehensive Income & Other	1.44	1.11	-4.03	-1.39	-0.08	-0.01
Shareholders' Equity	42.88	51.18	86.04	118.37	7.62	5.84
Total Liabilities & Equity	92.28	101.71	143.43	139.25	20.49	8.8
Total Debt	6.16	6.31	5.45	4.87	4.08	1.77
Net Cash (Debt)	80.64	89.26	127.42	128.34	11.74	5.57
Net Cash Growth	-23.53%	-29.95%	-0.72%	993.54%	110.59%	-
Net Cash Per Share	2.99	3.34	4.92	6.50	29.40	12.45
Filing Date Shares Outstanding	26.3	26.29	26.29	25.78	0.4	0.45
Total Common Shares Outstanding	26.3	26.29	26.29	25.78	0.4	0.45
Working Capital	76.06	83.96	118.58	125.26	10.89	6.2
Book Value Per Share	1.63	1.95	3.27	4.59	19.09	13.06
Tangible Book Value	42.88	51.18	86.04	118.37	7.62	5.84
Tangible Book Value Per Share	1.63	1.95	3.27	4.59	19.09	13.06
Buildings	-	0.38	0.12	0.12	0.11	0.04
Machinery	-	2.96	2.42	1.95	1.34	0.79

Source: S&P Capital IQ. Standard template. Financial Sources.